Descriptor English: | Ondansetron | ||||||
Descriptor Spanish: |
Ondansetrón
| ||||||
Descriptor Portuguese: | Ondansetron | ||||||
Descriptor French: | Ondansétron | ||||||
Entry term(s): |
4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)- Dihydrate, Ondansetron Monohydrochloride GR 38032F GR-38032F GR38032F Hydrochloride, Ondansetron Monohydrochloride Dihydrate, Ondansetron Monohydrochloride, Ondansetron ODT, Zofran Ondansetron Hydrochloride Ondansetron Monohydrochloride Ondansetron Monohydrochloride Dihydrate Ondansetron, (+,-)-Isomer Ondansetron, (R)-Isomer Ondansetron, (S)-Isomer SN 307 SN-307 SN307 Zofran Zofran ODT |
||||||
Tree number(s): |
D03.383.129.308.690 D03.633.100.473.144.500 D03.633.300.148.500 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D017294 | ||||||
Scope note: | A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Antiemetics Antipruritics Serotonin Antagonists Antipsychotic Agents Anti-Anxiety Agents |
||||||
Registry Number: | 4AF302ESOS | ||||||
CAS Type 1 Name: | 4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)- | ||||||
Previous Indexing: |
Imidazoles (1987-1992) |
||||||
Public MeSH Note: | 93; ONDANSETRON was indexed under IMIDAZOLES 1987-92 |
||||||
Online Note: | use ONDANSETRON (NM) to search ONDANSETRON 1987-92 |
||||||
History Note: | 93; was ONDANSETRON (NM) 1987-92 |
||||||
DeCS ID: | 30632 | ||||||
Unique ID: | D017294 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1993/01/01 | ||||||
Date of Entry: | 1992/05/19 | ||||||
Revision Date: | 2022/07/14 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Ondansetron
- Preferred
Ondansetron, (R)-Isomer
- Narrower
Ondansetron, (S)-Isomer
- Narrower
GR38032F
- Narrower
Zofran
- Narrower
Ondansetron Hydrochloride
- Narrower
SN-307
- Narrower
Zofran ODT
- Narrower
Concept UI |
M0026254 |
Scope note | A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties. |
Preferred term | Ondansetron |
Entry term(s) |
4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)- Ondansetron, (+,-)-Isomer |
Concept UI |
M0329264 |
Preferred term | Ondansetron, (R)-Isomer |
Concept UI |
M0329263 |
Preferred term | Ondansetron, (S)-Isomer |
Concept UI |
M0026255 |
Preferred term | GR38032F |
Entry term(s) |
GR 38032F GR-38032F |
Concept UI |
M0353338 |
Preferred term | Zofran |
Concept UI |
M0329262 |
Preferred term | Ondansetron Hydrochloride |
Entry term(s) |
Dihydrate, Ondansetron Monohydrochloride Hydrochloride, Ondansetron Monohydrochloride Dihydrate, Ondansetron Monohydrochloride, Ondansetron Ondansetron Monohydrochloride Ondansetron Monohydrochloride Dihydrate |
Concept UI |
M0353339 |
Preferred term | SN-307 |
Entry term(s) |
SN 307 SN307 |
Concept UI |
M000754320 |
Preferred term | Zofran ODT |
Entry term(s) |
ODT, Zofran |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey